CPZ is known to inhibit PI3K/Akt/mTOR in glioma and oral cancer cells (Jhou et al, 2021; Shin et al, 2013), and also induce ER stress in glioblastoma cell lines (Matteoni et al, 2021). This evidence concerns the gene CPZ and central nervous system cancer.